🇺🇸 FDA
Patent

US 8409616

Extended release opioid abuse deterrent compositions and methods of making same

granted A61KA61K31/485A61K47/32

Quick answer

US patent 8409616 (Extended release opioid abuse deterrent compositions and methods of making same) held by Acurx Pharmaceuticals, Inc. expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/485, A61K47/32, A61K47/34, A61K47/38